These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 24553004)

  • 1. Oxidative stress markers in affective disorders.
    Siwek M; Sowa-Kućma M; Dudek D; Styczeń K; Szewczyk B; Kotarska K; Misztakk P; Pilc A; Wolak M; Nowak G
    Pharmacol Rep; 2013; 65(6):1558-71. PubMed ID: 24553004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness.
    Maes M; Galecki P; Chang YS; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):676-92. PubMed ID: 20471444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants as antidepressants: fact or fiction?
    Scapagnini G; Davinelli S; Drago F; De Lorenzo A; Oriani G
    CNS Drugs; 2012 Jun; 26(6):477-90. PubMed ID: 22668245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis.
    Jiménez-Fernández S; Gurpegui M; Díaz-Atienza F; Pérez-Costillas L; Gerstenberg M; Correll CU
    J Clin Psychiatry; 2015 Dec; 76(12):1658-67. PubMed ID: 26579881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.
    Leonard B; Maes M
    Neurosci Biobehav Rev; 2012 Feb; 36(2):764-85. PubMed ID: 22197082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative & nitrosative stress in depression: why so much stress?
    Moylan S; Berk M; Dean OM; Samuni Y; Williams LJ; O'Neil A; Hayley AC; Pasco JA; Anderson G; Jacka FN; Maes M
    Neurosci Biobehav Rev; 2014 Sep; 45():46-62. PubMed ID: 24858007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats.
    Aboul-Fotouh S
    Pharmacol Biochem Behav; 2013 Mar; 104():105-12. PubMed ID: 23313551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.
    Maes M
    Neuro Endocrinol Lett; 2008 Jun; 29(3):287-91. PubMed ID: 18580840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New trends in the neurobiology and pharmacology of affective disorders.
    Lasoń W; Budziszewska B; Basta-Kaim A; Kubera M; Maes M
    Pharmacol Rep; 2013; 65(6):1441-50. PubMed ID: 24552991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.
    Maes M; Ruckoanich P; Chang YS; Mahanonda N; Berk M
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):769-83. PubMed ID: 20561554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches.
    Balmus IM; Ciobica A; Antioch I; Dobrin R; Timofte D
    Oxid Med Cell Longev; 2016; 2016():3975101. PubMed ID: 27563374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relevance of oxidative stress status in first episode and recurrent depression.
    Stefanescu C; Ciobica A
    J Affect Disord; 2012 Dec; 143(1-3):34-8. PubMed ID: 22840610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder.
    Maurya PK; Noto C; Rizzo LB; Rios AC; Nunes SO; Barbosa DS; Sethi S; Zeni M; Mansur RB; Maes M; Brietzke E
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Feb; 65():134-44. PubMed ID: 26348786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of zinc in the pathogenesis and treatment of affective disorders].
    Siwek MS; Wróbel A; Dudek D; Nowak G; Zieba A
    Psychiatr Pol; 2005; 39(5):899-909. PubMed ID: 16358590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&NS) pathways may explain cardiovascular disorders in ME/CFS.
    Maes M; Twisk FN
    Neuro Endocrinol Lett; 2009; 30(6):677-93. PubMed ID: 20038921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression.
    Roomruangwong C; Anderson G; Berk M; Stoyanov D; Carvalho AF; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():262-274. PubMed ID: 28941769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal plasticity: a link between stress and mood disorders.
    Calabrese F; Molteni R; Racagni G; Riva MA
    Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S208-16. PubMed ID: 19541429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative and Nitrosative Stress as Well as the Tryptophan Catabolites Pathway in Depressive Disorders.
    Wigner P; Czarny P; Galecki P; Sliwinski T
    Psychiatr Danub; 2017 Dec; 29(4):394-400. PubMed ID: 29197195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment.
    Siegel AN; Rodrigues N; Nasri F; Wilkialis L; Lipsitz O; Lee Y; Gill H; Subramaniapillai M; Phan L; Majeed A; Lui LMW; Rashidian H; Ho R; Toma S; Goldstein BI; Mansur RB; McIntyre RS; Rosenblat JD
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110032. PubMed ID: 32634540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.